97963-50-3 Usage
Uses
Used in Organic Synthesis:
2-(Difluoromethoxy)-1-fluoro-4-nitro-benzene is utilized as a building block in organic synthesis for the creation of complex molecules and new materials. Its unique functional groups contribute to the versatility and reactivity required in the synthesis of a wide range of organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(Difluoromethoxy)-1-fluoro-4-nitro-benzene is employed as a precursor in the development of novel drugs. Its potential applications in designing pharmaceuticals are being studied, with a focus on leveraging its reactivity and functional group properties to enhance drug efficacy and target specific biological pathways.
Used in Organic Chemistry Reactions:
2-(Difluoromethoxy)-1-fluoro-4-nitro-benzene is also used as a reactant in various organic chemistry reactions. Its functional groups enable it to participate in a range of chemical transformations, making it a valuable component in the synthesis of diverse organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 97963-50-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,9,6 and 3 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 97963-50:
(7*9)+(6*7)+(5*9)+(4*6)+(3*3)+(2*5)+(1*0)=193
193 % 10 = 3
So 97963-50-3 is a valid CAS Registry Number.
97963-50-3Relevant academic research and scientific papers
COMPOUNDS AND THEIR USES AS SPLEEN TYROSINE KINASE INHIBITORS
-
Paragraph 0224, (2021/12/28)
Provided are compounds of Formula (I) which can be used as Syk inhibitors and potently as therapeutic agents against diseases mediated by Syk.
TRIAZOLES AS NR2B RECEPTOR INHIBITORS
-
Paragraph 118-120, (2016/02/29)
Provided here in are compounds of Formula I having the structure: Also provided herein are compositions comprising compounds of Formula I and methods of using compounds of Formula I for the treatment of disorders, diseases or conditions mediated by GluN2B
